PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas (Q37329264)

19 August 2017

PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas (English)

1 reference

low-grade serous carcinoma

19 August 2017

0 references

8

Anais Malpica

1 reference

19 August 2017

10

Karen H Lu

1 reference

19 August 2017

12

Kwong-Kwok Wong

1 reference

19 August 2017

11

David M Gershenson

1 reference

19 August 2017

Celestine S Tung

1

1 reference

19 August 2017

Samuel C Mok

2

1 reference

19 August 2017

Yvonne T M Tsang

3

1 reference

19 August 2017

Zhifei Zu

4

1 reference

19 August 2017

Huijuan Song

5

1 reference

19 August 2017

Jinsong Liu

6

1 reference

19 August 2017

Michael T Deavers

7

1 reference

19 August 2017

Judith K Wolf

9

1 reference

19 August 2017

12 June 2009

1 reference

19 August 2017

1 reference

19 August 2017

22

1 reference

19 August 2017

9

1 reference

19 August 2017

1243-1250

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.92

19 August 2017

0 references

cites work

New insights into the pathogenesis of serous ovarian cancer and its clinical impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Early events in the pathogenesis of epithelial ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

A PANorama of PAX genes in cancer and development

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Getting your Pax straight: Pax proteins in development and disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Ovarian surface epithelium: biology, endocrinology, and pathology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

PAX2 suppresses apoptosis in renal collecting duct cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1)

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Incessant ovulation--a factor in ovarian neoplasia?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

Expression of the developmental and oncogenic PAX2 gene in human prostate cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2736318

PAX2: a reliable marker for nephrogenic adenoma

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.92

Aberrant expression of Pax-2 mRNA in renal cell carcinoma tissue and parenchyma of the affected kidney

21 January 2018

1 reference

12 December 2020

The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent

1 reference

12 December 2020

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

1 reference

12 December 2020

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

1 reference

12 December 2020

Grading ovarian serous carcinoma using a two-tier system

1 reference

12 December 2020

10.1038/MODPATHOL.2009.92

Identifiers

DOI

1 reference

release_y5end2uh7vf3plcutots2mc6y4

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y5end2uh7vf3plcutots2mc6y4

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

1 reference